Lung Cancer Europe publishes 2025 End of Year Report
Lung Cancer Europe has published its 2025 End of Year Report, highlighting a year of work across education, awareness, policy, research, and member engagement.
The report brings together key activity from 2025 and shows how the organisation continued to push for better lung cancer care, stronger advocacy, and more support for people affected by lung cancer across Europe.
The report sets out five main areas of focus during 2025: education and capacity building, the Get Checked campaign, the 10th Lung Cancer Europe Report on lung cancer and mental health, the Access to Treatment Atlas, and policy development. It also reflects the wider reality facing people affected by lung cancer, including ongoing inequalities in early diagnosis, access to treatment, and outcomes across Europe.
Among the highlights, Lung Cancer Europe delivered an AI Masterclass during its Annual General Meeting, ran two online webinars, and launched a public podcast session exploring the FT3 programme, From Testing to Targeted Treatment. The organisation also expanded its Member Forum work, holding one-to-one insight sessions with members to better understand national priorities and shape future collaboration.
A major part of the year was the 10th Lung Cancer Europe Report, focused on lung cancer and mental health. Based on responses from 2,204 participants across 31 countries, the report examined the psychological and emotional impact of lung cancer on people living with the disease and caregivers. Lung Cancer Europe also developed multilingual executive summaries, infographics, and social media assets to help share the findings more widely, and launched the report at ESMO in front of more than 60 attendees.
The report also looks back at Get Checked! 2025 – Get Supported!, which focused on the period after diagnosis and the need for practical, emotional, and social support throughout the lung cancer care pathway. According to the report, the campaign generated around 300,000 organic impressions across Lung Cancer Europe’s social media channels, while the campaign website recorded 17,925 page views during the campaign period.
Another key development in 2025 was the launch of the first Access to Treatment Atlas, mapping treatment availability and reimbursement across 30 European countries. The report describes 2025 as a set-up year for this work, with the Atlas introduced, discussed at a high-level event in the European Parliament, and positioned as a core part of Lung Cancer Europe’s policy agenda for 2026.
On the policy side, the report outlines the creation of a new Policy Steering Committee and a growing body of advocacy work, including clinical trials policy activity, statements linked to major international policy developments, and stronger partnerships with wider cancer and health stakeholders. It presents 2025 as a foundational year that helped build the structure for more targeted, evidence-based policy advocacy moving forward.
Overall, the 2025 End of Year Report gives a clear picture of Lung Cancer Europe’s work over the past year and the direction of travel for 2026. It brings together practical delivery, advocacy, lived experience, and policy development in one place, and underlines the need to keep lung cancer high on the agenda across Europe.